<?xml version="1.0" encoding="UTF-8"?>
<ref id="B18-molecules-26-01831">
 <label>18.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Liao</surname>
    <given-names>H.-C.</given-names>
   </name>
   <name>
    <surname>Chou</surname>
    <given-names>Y.-J.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>C.-C.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>S.-H.</given-names>
   </name>
   <name>
    <surname>Oswita</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>Y.-L.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.-L.</given-names>
   </name>
   <name>
    <surname>Syu</surname>
    <given-names>J.-L.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>C.-M.</given-names>
   </name>
   <name>
    <surname>Leu</surname>
    <given-names>C.-M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Andrographolide and its potent derivative exhibit anticancer effects against imatinib-resistant chronic myeloid leukemia cells by downregulating the Bcr-Abl oncoprotein</article-title>
  <source>Biochem. Pharmacol.</source>
  <year>2019</year>
  <volume>163</volume>
  <fpage>308</fpage>
  <lpage>320</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bcp.2019.02.028</pub-id>
  <pub-id pub-id-type="pmid">30822403</pub-id>
 </element-citation>
</ref>
